跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUBUTEX SUBLINGUAL TABLETS 0.4 mg - HSA Drug Approval Details
Approvals
/
HSA
/
SUBUTEX SUBLINGUAL TABLETS 0.4 mg
Approved
THERAPEUTIC
SUBUTEX SUBLINGUAL TABLETS 0.4 mg
RECKITT BENCKISER HEALTHCARE (UK) LTD
🇸🇬 Health Sciences Authority
Approval Date
Feb 3, 2000
Approval ID
423f780c79699403
Company
RECKITT BENCKISER HEALTHCARE (UK) LTD
Type
Therapeutic
Approval Details
Approval Id
423f780c79699403
Drug Name
SUBUTEX SUBLINGUAL TABLETS 0.4 mg
Product Name
SUBUTEX SUBLINGUAL TABLETS 0.4 mg
Approval Number
SIN11274P
Approval Date
2000-02-03
Registrant
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
N02AE01
Atc Item Name
buprenorphine
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
BUPRENORPHINE HCl EQV BUPRENORPHINE
0.4 mg
BUPRENORPHINE HCl EQV BUPRENORPHINE
0.4 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 3, 2000
Approval ID
423f780c79699403
Type
Therapeutic
Back to HSA Approvals